Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD

European Respiratory Journal

Volumn 33, Issue 6, 2009, Pages 1329-1337

  Dellaca R L ^a   Pompilio, P P ^a   Walker, P P ^b   Duffy, N ^b   Pedotti, A ^a   Calverley, P M A ^b  

^a POLITECNICO DI MILANO   (Italy)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Forced oscillation technique; Respiratory system reactance; Within breath impedance

Indexed keywords

BRONCHODILATING AGENT; LONG ACTING DRUG; SALBUTAMOL; SHORT ACTING DRUG;

ADULT; ARTICLE; BREATHING; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG MECHANICS; MALE; NEBULIZATION; OSCILLATION; PREDICTION; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY SYSTEM; SPIROMETRY;

ALBUTEROL; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INSPIRATORY CAPACITY; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; OSCILLOMETRY; PLETHYSMOGRAPHY; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MECHANICS; REST; SIGNAL PROCESSING, COMPUTER-ASSISTED; SPIROMETRY; TIDAL VOLUME;

EID: 69249125783     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00139608     Document Type: Article

References (41)

1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
2. Dellaca RL, Duffy N, Pompilio PP, et al. Expiratory flow limitation detected by forced oscillation and negative expiratory pressure. Eur Respir J 2007; 29: 363-374.
3. Calverley PM, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J 2005; 25: 186-199.
4. Diaz O, Villafranca C, Ghezzo H, et al. Breathing pattern and gas exchange at peak exercise in COPD patients with and without tidal flow limitation at rest. Eur Respir J 2001; 17: 1120-1127.
5. Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002; 121: 1042-1050.
6. Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664.
7. Anthonisen NR, Lindgren PG, Tashkin DP, et al. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 2005; 26: 45-51.
8. O'Donnell DE, Sciurba F, Celli B, et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006; 130: 647-656.
9. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 542-549.
10. Tantucci C, Duguet A, Similowski T, et al. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
11. Boni E, Corda L, Franchini D, et al. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. Thorax 2002; 57: 528-532.
12. Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 1995; 8: 306-313.
13. Dellaca RL, Santus P, Aliverti A, et al. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J 2004; 23: 232-240.
14. Dellacà RL, Rotger M, Aliverti A, et al. Noninvasive detection of expiratory flow limitation in COPD patients during nasal CPAP. Eur Respir J 2006; 27: 983-991.
15. van Noord JA, Smeets J, Clement J, et al. Assessment of reversibility of airflow obstruction. Am J Respir Crit Care Med 1994; 150: 551-554.
16. Farre R, Peslin R, Rotger M, et al. Forced oscillation total respiratory resistance and spontaneous breathing lung resistance in COPD patients. Eur Respir J 1999; 14: 172-178.
17. Chalker RB, Celli BR, Habib RH, et al. Respiratory input impedance from 4 to 256 Hz in normals and chronic airflow obstruction: comparisons and correlations with spirometry. Am Rev Respir Dis 1992; 146: 570-576.
18. Rabe KF, Beghe B, Luppi F, et al. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 2007; 175: 1222-1232.
19. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
20. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
21. Suki B, Lutchen KR. Pseudorandom signals to estimate apparent transfer and coherence functions of nonlinear systems: applications to respiratory mechanics. IEEE Trans Biomed Eng 1992; 39: 1142-1151.
22. Grimby G, Takishima T, Graham W, et al. Frequency dependence of flow resistance in patients with obstructive lung disease. J Clin Invest 1968; 47: 1455-1465.
23. Peslin R, Duvivier C, Didelon J, et al. Respiratory impedance measured with head generator to minimize upper airway shunt. J Appl Physiol 1985; 59: 1790-1795.
24. Kaczka DW, Ingenito EP, Lutchen KR. Technique to determine inspiratory impedance during mechanical ventilation: implications for flow limited patients. Ann Biomed Eng 1999; 27: 340-355.
25. Kaczka DW, Barnas GM, Suki B, et al. Assessment of time-domain analyses for estimation of low-frequency respiratory mechanical properties and impedance spectra. Ann Biomed Eng 1995; 23: 135-151.
26. Lutchen KR, Greenstein JL, Suki B. How inhomogeneities and airway walls affect frequency dependence and separation of airway and tissue properties. J Appl Physiol 1996; 80: 1696-1707.
27. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung functiontests. Eur Respir J 2005; 26: 948-968.
28. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-298.
29. Milic-Emili J. Expiratory flow limitation: Roger S. Mitchell Lecture. Chest 2000; 117: Suppl. 1, 219S-223S.
30. Otis AB, Mc Kerrow CB, Bartlett RA, et al. Mechanical factors in distribution of pulmonary ventilation. J Appl Physiol 1956; 8: 427-443.
31. Hadcroft J, Calverley PM. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Thorax 2001; 56: 713-720.
32. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31: 742-750.
33. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840.
34. Johnson MK, Birch M, Carter R, et al. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax 2007; 62: 299-306.
35. Stevenson NJ, Walker PP, Costello RW, et al. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 1510-1516.
36. O'Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86-94.
37. Habib RH, Suki B, Bates JH, Jackson AC. Serial distribution of airway mechanical properties in dogs: effects of histamine. J Appl Physiol 1994; 77: 554-566.
38. Gillis HL, Lutchen KR. How heterogeneous bronchoconstriction affects ventilation distribution in human lungs: a morphometric model. Ann Biomed Eng 1999; 27: 14-22.
39. Ito S, Ingenito EP, Arold SP, et al. Tissue heterogeneity in the mouse lung: effects of elastase treatment. J Appl Physiol 2004; 97: 204-212.
40. Jackson AC, Suki B, Ucar M, et al. Branching airway network models for analyzing high-frequency lung input impedance. J Appl Physiol 1993; 75: 217-227.
41. Borrill ZL, Houghton CM, Tal-Singer R, et al. The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD. Br J Clin Pharmacol 2008; 65: 244-252.